Citation Export
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, So Yeon | - |
dc.date.issued | 2023-06-01 | - |
dc.identifier.issn | 2306-5354 | - |
dc.identifier.uri | https://dspace.ajou.ac.kr/dev/handle/2018.oak/33502 | - |
dc.description.abstract | Leveraging recent advances in graph neural networks, our study introduces an application of graph convolutional networks (GCNs) within a correlation-based population graph, aiming to enhance Alzheimer’s disease (AD) prognosis and illuminate the intricacies of AD progression. This methodological approach leverages the inherent structure and correlations in demographic and neuroimaging data to predict amyloid-beta (A (Formula presented.)) positivity. To validate our approach, we conducted extensive performance comparisons with conventional machine learning models and a GCN model with randomly assigned edges. The results consistently highlighted the superior performance of the correlation-based GCN model across different sample groups in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset, suggesting the importance of accurately reflecting the correlation structure in population graphs for effective pattern recognition and accurate prediction. Furthermore, our exploration of the model’s decision-making process using GNNExplainer identified unique sets of biomarkers indicative of A (Formula presented.) positivity in different groups, shedding light on the heterogeneity of AD progression. This study underscores the potential of our proposed approach for more nuanced AD prognoses, potentially informing more personalized and precise therapeutic strategies. Future research can extend these findings by integrating diverse data sources, employing longitudinal data, and refining the interpretability of the model, which potentially has broad applicability to other complex diseases. | - |
dc.description.sponsorship | Data collection and sharing for this project were funded by the Alzheimer\\u2019s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging and the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following: AbbVie, Alzheimer\\u2019s Association; Alzheimer\\u2019s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research provides funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health ( www.fnih.org , accessed on 21 May 2023). The grantee organization was the Northern California Institute for Research and Education, and the study was coordinated by the Alzheimer\\u2019s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.title | Personalized Explanations for Early Diagnosis of Alzheimer’s Disease Using Explainable Graph Neural Networks with Population Graphs | - |
dc.type | Article | - |
dc.citation.title | Bioengineering | - |
dc.citation.volume | 10 | - |
dc.identifier.bibliographicCitation | Bioengineering, Vol.10 | - |
dc.identifier.doi | 10.3390/bioengineering10060701 | - |
dc.identifier.scopusid | 2-s2.0-85163715645 | - |
dc.identifier.url | www.mdpi.com/journal/bioengineering | - |
dc.subject.keyword | alzheimer’s disease | - |
dc.subject.keyword | amyloid-beta positivity | - |
dc.subject.keyword | explainable graph neural networks | - |
dc.subject.keyword | graph neural networks | - |
dc.subject.keyword | population graph | - |
dc.description.isoa | true | - |
dc.subject.subarea | Bioengineering | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.